Biotage AB 2024 IR
The report highlights Biotage's transition into a high-growth life science solutions player, achieving a 10.5 percent revenue growth in 2024. The company advanced its sustainability strategy by conducting a revised double materiality assessment in preparation for the CSRD and committing to the Science Based Targets initiative (SBTi). Key environmental efforts included switching major sites to renewable electricity and implementing an environmental checklist for product development to reduce solvent and chemical use. Socially, the company focused on workplace safety, reporting zero severe injuries, and worked to empower women in leadership, who represent 34 percent of management.
Company: Biotage AB
Sector: Health Care
Country: Sweden
Year: 2024
Type: IR
Pages: 112
Biotage AB
Annual And Sustainability Report
The report highlights Biotage's transition into a high-growth life science solutions player, achieving a 10.5 percent revenue growth in 2024. The company advanced its sustainability strategy by conducting a revised double materiality assessment in preparation for the CSRD and committing to the Science Based Targets initiative (SBTi). Key environmental efforts included switching major sites to renewable electricity and implementing an environmental checklist for product development to reduce solvent and chemical use. Socially, the company focused on workplace safety, reporting zero severe injuries, and worked to empower women in leadership, who represent 34 percent of management.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Net Zero Target
Employees